|
|
||||||||
Departments of Neurology (Drs. Younger, Rowland, Latov, Lange, Trojaborg, Miller, Lovelace, and Kim); Medicine (Division of Oncology) (Dr. Sherman); Pathology, Divisions of Clinical Pathology (Dr. Pesce), and Neuropathology (Dr. Hays), Presbyterian Hospital, Columbia University, College of Physicians and Surgeons, New York, NY.
From 1984 to 1988, 11 of 120 patients (9%) with motor neuron disease (MND) had paraproteins detected by serum immunofixation electrophoresis (IFE), compared with 4 (3%) by cellulose acetate gels: 1 patient had progressive spinal muscular atrophy, 5 patients had amyotrophic lateral sclerosis (ALS), and 5 patients had ALS with probable upper motor neuron signs. Four of 5 patients (80%) with cerebrospinal fluid (CSF) protein content above 75 mg/dl had paraproteins, as did 6 of 30 with values above 50 mg/dl. Four of 14 patients with cerebrospinal oligoclonal bands (OCB) also had paraproteins. Two patients with ALS, CSF protein content above 75 mg/dl, and paraproteinemia had lymphoma. We conclude the following about patients with MND: high CSF protein content (especially above 75 mg/dl) or CSF OCB makes paraproteinemia more likely; some of these patients may have lymphoma; there is an inordinately high occurrence of paraproteinemia in MND; and IFE on agarose is more sensitive than electrophoresis on cellulose acetate in detecting paraproteins. Syndromes of paraproteinemia and high CSF protein are not restricted to the lower motor neuron but qualify as "ALS" with coexisting upper motor neuron signs.
Address correspondence and reprint requests to Dr. David S. Younger, Neurological Institute of the Columbia-Presbyterian Medical Center, Box 53, 710 West 168th Street, New York, NY 10032-3784.
Supported by the Center Grants from the Muscular Dystrophy Association and NIH (NINCDS-NS11766) and GCRC (RR-00645).
Received June 23, 1989. Accepted for publication in final form September 15, 1989.
This article has been cited by other articles:
![]() |
W. J. Triggs and D. Cros Case 40-2007 -- A 38-Year-Old Man with Weakness in the Hands N. Engl. J. Med., December 27, 2007; 357(26): 2707 - 2715. [Full Text] [PDF] |
||||
![]() |
P. Kaufmann, S. L. Pullman, D. C. Shungu, S. Chan, A. P. Hays, M. L. Del Bene, M. A. Dover, M. Vukic, L. P. Rowland, and H. Mitsumoto Objective tests for upper motor neuron involvement in amyotrophic lateral sclerosis (ALS) Neurology, May 25, 2004; 62(10): 1753 - 1757. [Abstract] [Full Text] [PDF] |
||||
![]() |
J Kuipers-Upmeijer, A E J de Jager, J M Hew, J W Snoek, and T W van Weerden Primary lateral sclerosis: clinical, neurophysiological, and magnetic resonance findings J. Neurol. Neurosurg. Psychiatry, November 1, 2001; 71(5): 615 - 620. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Dabby, D. J. Lange, W. Trojaborg, A. P. Hays, R. E. Lovelace, T. H. Brannagan, and L. P. Rowland Inclusion Body Myositis Mimicking Motor Neuron Disease Arch Neurol, August 1, 2001; 58(8): 1253 - 1256. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. J. Triggs, D. Menkes, J. Onorato, R. S.- H. Yan, M. S. Young, K. Newell, H. W. Sander, O. Soto, K. H. Chiappa, and D. Cros Transcranial magnetic stimulation identifies upper motor neuron involvement in motor neuron disease Neurology, August 1, 1999; 53(3): 605 - 605. [Abstract] [Full Text] |
||||
![]() |
D. A. Chad and N. L. Harris Case 16-1999- A 71-Year-Old Man with Progressive Weakness and a Gammopathy N. Engl. J. Med., May 27, 1999; 340(21): 1661 - 1669. [Full Text] [PDF] |
||||
![]() |
A. H. Ropper and K. C. Gorson Neuropathies Associated with Paraproteinemia N. Engl. J. Med., May 28, 1998; 338(22): 1601 - 1607. [Full Text] [PDF] |
||||
![]() |
D. J. Lange, P. L. Murphy, B. Diamond, V. Appel, E. C. Lai, D. S. Younger, and S. H. Appel Selegiline Is Ineffective in a Collaborative Double-blind, Placebo-Controlled Trial for Treatment of Amyotrophic Lateral Sclerosis Arch Neurol, January 1, 1998; 55(1): 93 - 96. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.J. Triggs and M.A. Edgar Case 36-1995- A 61-year-old man with increasing weakness and atrophy of all extremities N. Engl. J. Med., November 23, 1995; 333(21): 1406 - 1412. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |